Publications by authors named "Louis Renzetti"

Claim this Profile
E
Editor's Note: Small-Molecule Inhibition of the Acyl-Lysine Reader ENL as a Strategy against Acute Myeloid Leukemia.
Yiman Liu, Qinglan Li, Fatemeh Alikarami, Declan R Barrett, Leila Mahdavi, Louis M Renzetti

Cancer Discov· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lead Optimization of Small Molecule ENL YEATS Inhibitors to Enable Studies: Discovery of TDI-11055.
Mayako Michino, Tanweer A Khan, Michael W Miller, Yoshiyuki Fukase, Jeremie Vendome, Louis M Renzetti

ACS Med Chem Lett· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Potent Mcl-1 Inhibitors: Structural Investigations on Macrocycles Originating from a DNA-Encoded Chemical Library Screen.
Koen F W Hekking, Sergio Maroto, Kees van Kekem, Frank S Haasjes, Jack C Slootweg, Louis M Renzetti

J Med Chem· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small-Molecule Inhibition of the Acyl-Lysine Reader ENL as a Strategy against Acute Myeloid Leukemia.
Yiman Liu, Qinglan Li, Fatemeh Alikarami, Declan R Barrett, Leila Mahdavi, Louis M Renzetti

Cancer Discov· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 2,4-1-Imidazole Carboxamides as Potent and Selective TAK1 Inhibitors.
Johan J N Veerman, Yorik B Bruseker, Eddy Damen, Erik H Heijne, Wendy van Bruggen, Louis M Renzetti

ACS Med Chem Lett· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Autotaxin Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis: A Clinical Candidate Discovered Using DNA-Encoded Chemistry.
John W Cuozzo, Matthew A Clark, Anthony D Keefe, Anna Kohlmann, Mark Mulvihill, Louis M Renzetti

J Med Chem· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of N-acyl 4-(3-pyridonyl)phenylalanine derivatives and their orally active prodrug esters as dual acting α4β1 and α4β7 receptor antagonists.
Jefferson W Tilley, Achyutharao Sidduri, Jianping Lou, Gerry Kaplan, Nadine Tare, Louis Renzetti

Bioorg Med Chem Lett· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of N-acyl 4-(5-pyrimidine-2,4-dionyl)phenylalanine derivatives and their orally active prodrug esters as dual-acting alpha4-beta1 and alpha4-beta7 receptor antagonists.
Achyutharao Sidduri, Jefferson W Tilley, Jianping Lou, Nadine Tare, Gary Cavallo, Louis Renzetti

Bioorg Med Chem Lett· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mRNA level of Charcot-Leyden crystal protein/galectin-10 is a marker for CRTH2 activation in human whole blood in vitro.
Tai-An Lin, Galina Kourteva, Holly Hilton, Hongli Li, Nadine S Tare, Louis M Renzetti

Biomarkers· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KU812 cells provide a novel in vitro model of the human IL-33/ST2L axis: functional responses and identification of signaling pathways.
Nadine Tare, Hongli Li, Andrew Morschauser, Javier Cote-Sierra, Grace Ju, Louis Renzetti

Exp Cell Res· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular and molecular characterization of ozone-induced pulmonary inflammation in the Cynomolgus monkey.
Alexandra Hicks, Galina Kourteva, Holly Hilton, Hongli Li, Tai-An Lin, Louis M Renzetti

Inflammation· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of LTB4 receptor antagonism on pulmonary inflammation in rodents and non-human primates.
Alexandra Hicks, Robert Goodnow, Gary Cavallo, Shahid A Tannu, Jessica D Ventre, Louis M Renzetti

Prostaglandins Other Lipid Mediat· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel and potent leukotriene B4 receptor antagonists. Part 1.
Robert A Goodnow, Alexandra Hicks, Achyutharao Sidduri, Agnieszka Kowalczyk, Romyr Dominique, Louis M Renzetti

J Med Chem· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the effect of multiple-dose administration of R411, a dual alpha4beta1-alpha4beta7 integrin antagonist on the major CYP isoform activities in healthy volunteers.
Youssef Hijazi, Horst Welker, Albert E Dorr, Karl Frank, Louis M Renzetti

Eur J Clin Pharmacol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, safety, and tolerability of R411, a dual alpha4beta1-alpha4beta7 integrin antagonist after oral administration at single and multiple once-daily ascending doses in healthy volunteers.
Youssef Hijazi, Horst Welker, Albert E Dorr, Jian-Ping Tang, Roger Blain, Louis M Renzetti

J Clin Pharmacol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-Cycloalkanoyl-L-phenylalanine derivatives as VCAM/VLA-4 antagonists.
Achyutharao Sidduri, Jefferson W Tilley, Kenneth Hull, Jian Ping Lou, Gerry Kaplan, Louis M Renzetti

Bioorg Med Chem Lett· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-Aroyl-L-phenylalanine derivatives as VCAM/VLA-4 antagonists.
Achyutharao Sidduri, Jefferson W Tilley, Jian Ping Lou, Li Chen, Gerry Kaplan, Louis M Renzetti

Bioorg Med Chem Lett· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis